Abstract
To simulate new strategies for designing effective drugs against bird flu, we have carried out extensive studies by using various computer-aided drug design tools. Molecule AG7088 was first docked to the active site of H5N1 avian influenza neuraminidase (PBD code: 2HTY). The results thus obtained were compared with those by docking zanamivir (Relenza) and oseltamivir (Tamiflu) to the same receptor, respectively. It has been found that the compound AG7088 has better binding energy than zanamivir and oseltamivir. Thus, it was adopted as a template to perform the similarity search of 392,698 druggable compounds in order to find the leading candidates for the next step of modeling studies. Nine analogs of AG7088 were singled out through a series of docking studies. Finally, the molecular dynamics simulation technique was utilized to investigate into the binding interactions between the H5N1 receptor and the nine analogs, with a focus on the binding pocket, intermolecular surfaces and hydrogen bonds. This study may be used as a guide for mutagenesis studies for designing new inhibitors against H5N1.
Keywords: H5N1, avian influenza, bird flu, drug design, neuraminidase, structural bioinformatics, active site, AG7088
Medicinal Chemistry
Title: Binding Mechanism of H5N1 Influenza Virus Neuraminidase with Ligands and its Implication for Drug Design
Volume: 5 Issue: 3
Author(s): Ke Gong, Lin Li, Jing-Fang Wang, Feng Cheng, Dong-Qing Wei and Kuo-Chen Chou
Affiliation:
Keywords: H5N1, avian influenza, bird flu, drug design, neuraminidase, structural bioinformatics, active site, AG7088
Abstract: To simulate new strategies for designing effective drugs against bird flu, we have carried out extensive studies by using various computer-aided drug design tools. Molecule AG7088 was first docked to the active site of H5N1 avian influenza neuraminidase (PBD code: 2HTY). The results thus obtained were compared with those by docking zanamivir (Relenza) and oseltamivir (Tamiflu) to the same receptor, respectively. It has been found that the compound AG7088 has better binding energy than zanamivir and oseltamivir. Thus, it was adopted as a template to perform the similarity search of 392,698 druggable compounds in order to find the leading candidates for the next step of modeling studies. Nine analogs of AG7088 were singled out through a series of docking studies. Finally, the molecular dynamics simulation technique was utilized to investigate into the binding interactions between the H5N1 receptor and the nine analogs, with a focus on the binding pocket, intermolecular surfaces and hydrogen bonds. This study may be used as a guide for mutagenesis studies for designing new inhibitors against H5N1.
Export Options
About this article
Cite this article as:
Gong Ke, Li Lin, Wang Jing-Fang, Cheng Feng, Wei Dong-Qing and Chou Kuo-Chen, Binding Mechanism of H5N1 Influenza Virus Neuraminidase with Ligands and its Implication for Drug Design, Medicinal Chemistry 2009; 5 (3) . https://dx.doi.org/10.2174/157340609788185936
DOI https://dx.doi.org/10.2174/157340609788185936 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diversity in Medicinal Chemistry Space
Current Topics in Medicinal Chemistry <i>De Novo</i> Vasculitis after COVID-19 Vaccination
Current Rheumatology Reviews Antitubercular Drug Development: Current Status and Research Strategies
Mini-Reviews in Medicinal Chemistry The Patient with a Single Cardiac Ventricle
Current Pediatric Reviews Microwave-Assisted Combinatorial Synthesis of 2-Alkyl-2-(NArylsulfonylindol- 3-yl)-3-N-Acyl-5-Aryl-1,3,4-Oxadiazolines as Anti-HIV- 1 Agents
Combinatorial Chemistry & High Throughput Screening 30 Years Lost in Anesthesia Theory
Cardiovascular & Hematological Agents in Medicinal Chemistry Recent Progress of Medicinal Chemistry Research on Peroxisome Proliferator-Activated Receptor (PPAR) Ligands for the Treatment of Metabolic Syndrome
Current Bioactive Compounds Evaluation of the Binding Affinity of Anti-Viral Drugs against Main Protease of SARS-CoV-2 Through a Molecular Docking Study
Infectious Disorders - Drug Targets Structure-Activity Relationships of Neuroactive Steroids Acting on the GABAA Receptor
Current Medicinal Chemistry Soluble Epoxide Hydrolase: A Novel Target for the Treatment of Hypertension
Recent Patents on Cardiovascular Drug Discovery Diabetes Mellitus Type 1 During COVID-19: Psychological Symptoms and Eating Attitudes
Current Diabetes Reviews Histidine Kinases as Antimicrobial Targets: Prospects and Pitfalls
Mini-Reviews in Medicinal Chemistry Insect Peptides – Perspectives in Human Diseases Treatment
Current Medicinal Chemistry Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp)
Current Medicinal Chemistry Insights into the Structural Complexities of SARS-CoV-2 for Therapeutic and Vaccine Development
Combinatorial Chemistry & High Throughput Screening Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Template: Organic and Medicinal Chemistry Approach
Current Organic Chemistry Skirmishing Disconcerting Covid-19 by Drug Reassigning
Applied Drug Research, Clinical Trials and Regulatory Affairs Inflammatory Mechanisms in Myocardial Infarction
Current Drug Targets - Inflammation & Allergy Study of SARS-nCoV2 Indian Isolates Gaining Insights into Mutation Frequencies, Protein Stability and Prospective Effect on Pathogenicity
Coronaviruses Recent Advances in Multidimensional QSAR (4D-6D): A Critical Review
Mini-Reviews in Medicinal Chemistry